SUPPORT for Patients and Communities Reauthorization Act of 2025

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

(a)

Short Title.— This Act may be cited as the “SUPPORT for Patients and Communities Reauthorization Act of 2025”.

(b)

Table of Contents.— The table of contents for this Act is as follows:

Sec. 1. Short title; table of contents.

TITLE I— PREVENTION

Sec. 101. Prenatal and postnatal health.

Sec. 102. Monitoring and education regarding infections associated with illicit drug use and other risk factors.

Sec. 103. Preventing overdoses of controlled substances.

Sec. 104. Support for individuals and families impacted by fetal alcohol spectrum disorder.

Sec. 105. Promoting state choice in PDMP systems.

Sec. 106. First responder training program.

Sec. 107. Donald J. Cohen National Child Traumatic Stress Initiative.

Sec. 108. Protecting suicide prevention lifeline from cybersecurity incidents.

Sec. 109. Monitoring and reporting of child, youth, and adult trauma.

Sec. 110. Bruce’s law.

Sec. 111. Guidance on at-home drug disposal systems.

Sec. 112. Assessment of opioid drugs and actions.

Sec. 113. Grant program for State and Tribal response to opioid use disorders.

TITLE II— TREATMENT

Sec. 201. Residential treatment program for pregnant and postpartum women.

Sec. 202. Improving access to addiction medicine providers.

Sec. 203. Mental and behavioral health education and training grants.

Sec. 204. Loan repayment program for substance use disorder treatment workforce.

Sec. 205. Development and dissemination of model training programs for substance use disorder patient records.

Sec. 206. Task force on best practices for trauma-informed identification, referral, and support.

Sec. 207. Grants to enhance access to substance use disorder treatment.

Sec. 208. State guidance related to individuals with serious mental illness and children with serious emotional disturbance.

Sec. 209. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone.

Sec. 210. References to opioid overdose reversal agents in HHS grant programs.

Sec. 211. Roundtable on using health information technology to improve mental health and substance use care outcomes.

TITLE III— RECOVERY

Sec. 301. Building communities of recovery.

Sec. 302. Peer support technical assistance center.

Sec. 303. Comprehensive opioid recovery centers.

Sec. 304. Youth prevention and recovery.

Sec. 305. CAREER Act.

Sec. 306. Addressing economic and workforce impacts of the opioid crisis.

Sec. 307. Review of information related to funding opportunities under programs administered by SAMHSA.

TITLE IV— MISCELLANEOUS MATTERS

Sec. 401. Delivery of a controlled substance by a pharmacy to a prescribing practitioner.

Sec. 402. Required training for prescribers of controlled substances.